Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
Abstract To estimate dopaminergic dysfunction in patients with Parkinson disease (PD) during the premotor stage and to investigate the effect of genetic factors on the trajectories. Using longitudinal dopamine transporter single-photon emission computed tomography data from 367 sporadic PD (sPD), 72...
Guardado en:
Autores principales: | Myung Jun Lee, Kyoungjune Pak, Han-Kyeol Kim, Kelly N. Nudelman, Jong Hun Kim, Yun Hak Kim, Junho Kang, Min Seok Baek, Chul Hyoung Lyoo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9165daac7d7b4ce4bd09c0766ac5a5ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Temporal trajectory of biofluid markers in Parkinson’s disease
por: Min Seok Baek, et al.
Publicado: (2021) -
Longitudinal analysis of premotor anthropometric and serological markers of Parkinson’s disease
por: Katsunori Yokoi, et al.
Publicado: (2020) -
Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease
por: Soojin Kim, et al.
Publicado: (2021) -
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: MA Qamar, et al.
Publicado: (2017) -
Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
por: Sangwoo Ham, et al.
Publicado: (2017)